Professional Documents
Culture Documents
Carcinoma Endometrium
Carcinoma Endometrium
Carcinoma Endometrium
Cancer
Presented by
Dr/ Ahmed Walid Anwar
Assistant professor of Obs & Gyn
Benha Faculty of Medicine
Endometrial cancer
– The most common ♀ pelvic genital cancer .
– The life time risk of developing endometrial Ca is
2.4% in white women & 1.3% in black (In USA).
– Age:
Peak incidence in the 6th & 7th decade of life (disease of
postmenopausal women).
Only 2-5% occur before 40 years.
– Higher survival rate due to early diagnosis ( 75%
diagnosed in Stage I).
– Estrogen has been implicated as a causative factor.
These risk factors are only helpful in identifying
women at risk for type I disease.
Risk factors for endometrial cancer
OLD AUNT
O=Obesity
L=Late menopause
D=Diabetes mellitus
A=cAncer: ovarian, breast, colon
U=Unopposed estrogen: PCOS, anovulation, HRT
N=Nulliparity
T=Tamoxifen, chronic use
Causes of high unopposed estrogen
Exogenous Estrogen: Estrogen Replacement
Therapy in postmenopausal women.
Endogenous Estrogen:
– Increased secretion : e.g. feminizing ovarian tumors
(granulose cell tumor).
– Increased androgen precursors: e.g. androgen secreting
tumors, liver diseases, chronic an-ovulation (PCOS), or
stress.
– Increased aromatization: e.g. obesity, liver diseases, or
hyperthyroidism.
– Increased free estrogen due to decreased level of
SHBG.
Protective Factors
1. Oral contraceptives: Protective effect probably due to progesterone
Decreases both the risk of ovarian and endometrial cancer (RR = 0.6 if
1. Physical activity
higher number of pregnancies and who breast-feed for more than 18 months.
3. Diet: low in saturated fats and high in fruits and vegetables and soy -based foods as
a regular part of the diet may lower the risk of endometrial cancer.
4. Smoking
Other Types of Uterine Cancer
Leiomyosarcoma
– Rapidly growing fibroid should be evaluated
Stromal sarcoma
Carcinosarcoma (MMMT)
MMMT
leiomyosarcom
a
Spread Patterns
Direct extension
– most common
Transtubal
Lymphatic
– Pelvic usually first, then para-aortic
Hematogenous
– Lung most common
– Liver, brain, bone
Endometrial hyperplasia
Endometrial Intraepithelial
Neoplasia (EIN) system
Def: EIN is a histopathological presentation of premalignant
endometrial disease which elevated the risk of {endometrioid
(Type I) endometrial adenocarcinoma}.
Significance:
– Women with endometrial hyperplasia subdivided into EIN
versus non-EIN categories.
– Progression to cancer more than one year following
EIN diagnosis is 45 times more likely compared to
women without EIN.
Representation
Asymptomatic : Endometrial cells on Pap
B: The “classic symptom” is abnormal uterine Bleeding
20-30% of women with post-menopausal bleeding will
have uterine cancer.
( the risk is higher the farther they are away from
menopause)
C
D
E
P (Pain, Pressure)
Metastasis
Diagnostic evaluation
Outpatient endometrial biopsy with the Pipelle catheter is
reliable and accurate for the detection of disease in most cases of
endometrial cancer (level of evidence: A).
Detection rates by pipelle was :
– 91 and 99% for endometrial ca.
– 81% for hyperplasia was
Hysteroscopic-guided endometrial biopsy remains the gold
standard for endometrial cancer diagnosis (level of evidence:
A ).
Diagnostic evaluation
Transvaginal ultrasonography is highly sensitive
and specific in predicting the presence of endometrial
cancer and can be used to select patients for
endometrial biopsy (level of evidence: B).
If symptomatology persists despite negative findings
from the previously cited tests, further evaluation is
justified because none of these tests have 100%
sensitivity (level of evidence: B).
Metastatic evaluation
Routine preoperative assessment of endometrial cancer
patients with imaging tests evaluating for metastasis is not
necessary as it is surgically staged disease (level of evidence:
A).